Incidence of hypothyroidism in patients undergoing radiotherapy for head and neck cancer at the Tellippalai Trail cancer hospital

Research project overview

Head and neck cancers (HNCs) are a significant global health concern with substantial morbidity and mortality. The relatively low metastasis rate of HNCs allows for effective management through localized treatments like surgery and radiotherapy. However, radiation-induced hypothyroidism (RIH) can occur when the thyroid gland is inadvertently exposed during radiotherapy. This exposure damages thyroid tissue, compromising hormone production. Taking focused history during follow-ups is crucial for early detection of RIH. This study aims to investigate the incidence of RIH in patients who have received neck radiotherapy in Northern Sri Lanka.

Objective

To Identify the incidence of RIH among patients receiving radiotherapy to H & N cancers at the Tellippalai Trail Cancer Hospital (TTCH) between 2013/01/01 – 2022/12/31.